Cardiol Therapeutics (CRDL.TO) Q2 2025 Earnings

16MayConfirmed
Q2 2024
Q3 2024
Q4 2024
Q2 2025
-0.19
-0.16
-0.13
-0.1

Details

Expected EPS
-0.11153922574199998
Actual EPS
-0.09699063108
Surprise EPS
0.01
Surprise Percent
+13.04%

Description

Cardiol Therapeutics (CRDL.TO) has reported earnings of -0.09699063108 per share for Q2 2025.

0 Comments

Share your thoughts